Evaluation of disk diffusion method for determining eberconazole susceptibility of dermatophytes and influence of culture medium

Antimicrobial Agents and Chemotherapy

Volumn 49, Issue 5, 2005, Pages 2116-2118

  Fernández Torres, Belkys ^a   Inza, Isabel ^a   Guarro, Josep ^a  

^a UNIVERSITAT ROVIRA I VIRGILI   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

EBERCONAZOLE;

ANTIBIOTIC SENSITIVITY; ANTIFUNGAL ACTIVITY; ARTICLE; CORRELATION ANALYSIS; CULTURE MEDIUM; DERMATOPHYTE; DIFFUSION; DISK DIFFUSION METHOD; FUNGAL STRAIN; FUNGUS CULTURE; INTERMETHOD COMPARISON; METHODOLOGY; MICRODILUTION METHOD; NONHUMAN; PRIORITY JOURNAL;

ANTI-INFECTIVE AGENTS, LOCAL; ARTHRODERMATACEAE; ASPERGILLUS FUMIGATUS; CANDIDA; CULTURE MEDIA; CYCLOHEPTANES; IMIDAZOLES; MICROBIAL SENSITIVITY TESTS;

EID: 18244403741     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.49.5.2116-2118.2005     Document Type: Article

References (20)

1. Arikan, S., M. Lozano-Chiu, V. Paetznick, and J. H. Rex. 2001. In vitro susceptibility testing methods for caspofungin against Aspergillus and Fusarium isolates. Antimicrob. Agents Chemother. 45:327-330.
2. Denning, D. W., Radford, K. L. Oakley, L. Hall, E. M. Johnson, and D. W. Warnock. 1997. Correlation between in vitro susceptibility testing to itraconazole and in vivo outcome of Aspergillus fumigatus infection. J. Antimicrob. Chemother. 40:401-414.
3. Fernández-Torres, B., I. Inza, and J. Guarro. 2003. In vitro activities of the new antifungal drug eberconazole and three other topical agents against 200 strains of dermatophytes. J. Clin. Microbiol. 41:5209-5211.
4. Fernández-Torres, B., F. J. Cabañes, A. J. Carrillo-Muñoz, A. Esteban, I. Inza, L. Abarca, and J. Guarro. 2002. Collaborative evaluation of optimal antifungal susceptibility testing conditions for dermatophytes. J. Clin. Microbiol. 40:3999-4003.
5. Liebowitz, L. D., H. R. Ashbee, E. G. V. Evans, Y. Chong, N. Mallatova, M. Zaidi, D. Gibbs, and Global Antifungal Surveillance Group. 2001. A two year global evaluation of the susceptibility of Candida species to fluconazole by disk diffusion. Diagn. Microbiol. Infect. Dis. 4:27-33.
6. Llop, C., J. Sala, M. D. Riba, and J. Guarro. 1999. Antimicrobial susceptibility testing of dematiaceous filamentous fungi: effect of medium composition at different temperatures and times of reading. Mycopathologia 148:25-31.
7. Lozano-Chiu, M., V. L. Paetznick, M. A. Ghannoum, and J. H. Rex. 1998. Detection of resistance to amphotericin B among Cryptococcus neoformans clinical isolates: performances of three different media assessed by using E-test and National Committee for Clinical Laboratory Standards M27-A methodologies. J. Clin. Microbiol. 36:2817-2822.
8. Macura, A. B. 1993. In vitro susceptibility of dermatophytes to antifungal drugs: a comparison of two methods. Int. J. Dermatol. 32:533-536.
9. Manavathu, E. K., U. Nune, K. Kanuri, P. H. Chandrasekar, and O. C. Abraham. 2000. Effect of test medium on in vitro susceptibility testing results for Aspergillus fumigatus. Rev. Iberoam. Micol. 17:107-110.
10. Matar, M. J., L. Ostrosky-Zeichner, V. L. Paetznick, J. R. Rodriguez, E. Chen, and J. H. Rex. 2003. Correlation between E-test, disk diffusion, and microdilution methods for antifungal susceptibility testing of fluconazole and voriconazole. Antimicrob. Agents Chemother. 47:1647-1651.
11. Müller, F.-M., O. Kurzai, J. Hacker, M. Frosch, and F. Múhlschlegel. 2001. Effect of the growth medium on the in vitro antifungal activity of micafungin (FK-463) against clinical isolates of Candida dubliniensis. J. Antimicrob. Chemother. 48:713-715.
12. National Committee for Clinical Laboratory Standards. 2002. Reference method for broth dilution antifungal susceptibility testing of yeasts. Approved standard M27-A2. National Committee for Clinical Laboratory Standards, Wayne, Pa.
13. National Committee for Clinical Laboratory Standards. 2003. Method for antifungal disk diffusion susceptibility testing of yeasts: proposed guideline M44-P. National Committee for Clinical Laboratory Standards, Wayne, Pa.
14. Odabasi, Z., V. Paetznick, B. P. Goldstein, J. H. Rex, and L. Ostrosky-Zeichner. 2003. Disk diffusion-based methods for determining Candida parapsilosis susceptibility to anidulafungin. Antimicrob. Agents Chemother. 47:3018-3020,
15. Odds, F., J. Ausma, F. Van Gerven, F. Woestenborghs, L. Meerpoel, J. Heeres, H. Vanden Bossche, and M. Borgers. 2004. In vitro and in vivo activities of the novel azole antifungal agent r126638. Antimicrob. Agents Chemother. 48:388-391.
16. Pfaller, M. A., S. A. Messer, A. Karlsson, and A. Bolmström. 1998. Evaluation of the Etest method for determining fluconazole susceptibilities of 402 clinical yeast isolates by using three different agar media. J. Clin. Microbiol. 36:2586-2589.
17. Tatsumi, Y., M. Yokoo, H. Senda, and K. Kakehi. 2002. Therapeutic efficacy of topically applied KP-103 against experimental tinea unguium in guinea pigs in comparison with amorolfine and terbinafine. Antimicrob. Agents Chemother. 46:3797-3801.
18. Torres-Rodriguez, J. M., R. Mendez, O. López-Jodra, Y. Morera, M. Espasa, T. Jimenez, and C. Lagunas. 1999. In vitro susceptibilities of clinical yeast isolates to the new antifungal eberconazole compared with their susceptibilities to clotrimazole and ketoconazole. Antimicrob. Agents Chemother. 43: 1258-1259.
19. Tortorano, A. M., E. Dannaoui, M. Cogliati, M. A. Piens, A. L. Rigoni, R. Grillot, M. A. Viviani, and E. Network. 2000. Evaluation of different in vitro procedures for testing amphotericin B and itraconazole susceptibility of Aspergillus fumigatus. J. Mycol. Med. 10:123-127.
20. Venugopal, P. V., and T. V. Venugopal. 1994. Disk diffusion susceptibility testing of dermatophytes with allylamines. Int. J. Dermatol. 33:730-732.